The importance of being grade 3 in primary non-muscle invasive bladder cancer by B.W.G. Van Rhijn, I.J. Beijert, P. Mariappan, F. Liedberg

Get full text

Identifying changes in the tumor micro-environment in muscle-invasive bladder cancer after neo-adjuvant chemotherapy by J. van Dorp, A. Gil Jimenez, C.S. Voskuilen, B.W.G. Van Rhijn, M.S. Van Der Heijden

Get full text

Clinical impact of [18F] Fluorodeoxyglucose positron emission tomography/computed tomography on management of patients with muscle-invasive bladder cancer by C.S. Voskuilen, E.J. Van Gennep, E. Vegt, M. Donswijk, E.E. Fransen Van De Putte, H.G. Van Der Poel, S. Horenblas, B.W.G. Van Rhijn, K. Hendricksen, L.S Mertens

Get full text

Feasibility and efficacy of preoperative ipilimumab/nivolumab in loco-regionally advanced urothelial cancer of the bladder (NABUCCO) by B.W.G. Van Rhijn, N. Van Dijk, L. Smit, K. Hendricksen, J.M. De Feijter, E. Bekers, A. Broeks, Y. Lubeck, K. Sikorska, T. Schumacher, P. Kvistborg, T. Boellaard, C.U. Blank, M.S. Van Der Heijden

Get full text

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE tr... by C.F. Stockem, J.J.J. Mellema, B.W.G. van Rhijn, T.N. Boellaard, M.L. van Montfoort, S. Balduzzi, J.L. Boormans, M. Franckena, R.P. Meijer, D.G.J. Robbrecht, B.B.M. Suelmann, E.E. Schaake, M.S. van der Heijden

Get full text